Fluorinated Carbohydrates for F-positron Emission Tomography (PET)

Overview

Journal Chem Soc Rev

Specialty Chemistry

Date 2023 May 12

PMID 37171037

Authors

Emma Campbell

Christina Jordan

Ryan Gilmour

Affiliations

Soon will be listed here.

Abstract

Carbohydrate diversity is foundational in the molecular literacy that regulates cellular function and communication. Consequently, delineating and leveraging this structure-function interplay continues to be a core research objective in the development of candidates for biomedical diagnostics. A totemic example is the ubiquity of 2-deoxy-2-[F]-fluoro-D-glucose (2-[F]-FDG) as a radiotracer for positron emission tomography (PET), in which metabolic trapping is harnessed. Building on this clinical success, more complex sugars with unique selectivities are gaining momentum in molecular recognition and personalised medicine: this reflects the opportunities that carbohydrate-specific targeting affords in a broader sense. In this Tutorial Review, key milestones in the development of 2-[F]-FDG and related glycan-based radiotracers for PET are described, with their diagnostic functions, to assist in navigating this rapidly expanding field of interdisciplinary research.

Citing Articles

Probing the Origin of Affinity in the GM1-Cholera Toxin Complex through Site-Selective Editing with Fluorine.

Jordan C, Hayashi T, Lobbert A, Fan J, Teschers C, Siebold K ACS Cent Sci. 2024; 10(8):1481-1489.

PMID: 39220706 PMC: 11363330. DOI: 10.1021/acscentsci.4c00622.

Radioactive Molecules 2021-2022.

Jensen S Molecules. 2024; 29(1).

PMID: 38202848 PMC: 10780926. DOI: 10.3390/molecules29010265.

Positron scattering from structurally related biomolecules.

Mahla S, Antony B RSC Adv. 2024; 14(2):1397-1406.

PMID: 38174274 PMC: 10763659. DOI: 10.1039/d3ra06227a.

References

Eberl S, Eriksson T, Svedberg O, Norling J, Henderson D, Lam P . High beam current operation of a PETtrace™ cyclotron for 18F- production. Appl Radiat Isot. 2012; 70(6):922-30. DOI: 10.1016/j.apradiso.2012.03.007. View

Alauddin M, Shahinian A, Park R, Tohme M, Fissekis J, Conti P . In vivo evaluation of 2'-deoxy-2'-[(18)F]fluoro-5-iodo-1-beta-D-arabinofuranosyluracil ([18F]FIAU) and 2'-deoxy-2'-[18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil ([18F]FEAU) as markers for suicide gene expression. Eur J Nucl Med Mol Imaging. 2007; 34(6):822-9. DOI: 10.1007/s00259-006-0305-1. View

Tewson T . Synthesis of no-carrier-added fluorine- 18 2-fluoro-2-deoxy-D-glucose. J Nucl Med. 1983; 24(8):718-21. View

Radu C, Shu C, Nair-Gill E, Shelly S, Barrio J, Satyamurthy N . Molecular imaging of lymphoid organs and immune activation by positron emission tomography with a new [18F]-labeled 2'-deoxycytidine analog. Nat Med. 2008; 14(7):783-8. PMC: 2720060. DOI: 10.1038/nm1724. View

Hamacher K, Coenen H, Stocklin G . Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med. 1986; 27(2):235-8. View

Ajenjo J, Destro G, Cornelissen B, Gouverneur V . Closing the gap between F and F chemistry. EJNMMI Radiopharm Chem. 2021; 6(1):33. PMC: 8464544. DOI: 10.1186/s41181-021-00143-y. View

Vaupel P, Mayer A . Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007; 26(2):225-39. DOI: 10.1007/s10555-007-9055-1. View

Sun H, Collins J, Mangner T, Muzik O, Shields A . Imaging [18F]FAU [1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl) uracil] in dogs. Nucl Med Biol. 2002; 30(1):25-30. DOI: 10.1016/s0969-8051(02)00376-1. View

Alauddin M, Shahinian A, Park R, Tohme M, Fissekis J, Conti P . Biodistribution and PET imaging of [(18)F]-fluoroadenosine derivatives. Nucl Med Biol. 2007; 34(3):267-72. PMC: 1905838. DOI: 10.1016/j.nucmedbio.2006.12.009. View

10.

Levy S, Elmaleh D, Livni E . A new method using anhydrous [18F]fluoride to radiolabel 2-[18F]fluoro-2-deoxy-D-glucose. J Nucl Med. 1982; 23(10):918-22. View

11.

Fujiwara T, Kubota K, Sato T, Matsuzawa T, Tada M, Iwata R . N-[18F]fluoroacetyl-D-glucosamine: a potential agent for cancer diagnosis. J Nucl Med. 1990; 31(10):1654-8. View

12.

Wojnowska M, Feng X, Chen Y, Deng H, OHagan D . Identification of Genes Essential for Fluorination and Sulfamylation within the Nucleocidin Gene Clusters of Streptomyces calvus and Streptomyces virens. Chembiochem. 2022; 24(5):e202200684. PMC: 10946740. DOI: 10.1002/cbic.202200684. View

13.

Jacobson O, Kiesewetter D, Chen X . Fluorine-18 radiochemistry, labeling strategies and synthetic routes. Bioconjug Chem. 2014; 26(1):1-18. PMC: 4306521. DOI: 10.1021/bc500475e. View

14.

Khan S . Creating positron emission tomography facility in remote areas. Indian J Nucl Med. 2014; 29(4):208-9. PMC: 4228582. View

15.

Buck A, Bommer M, Stilgenbauer S, Juweid M, Glatting G, Schirrmeister H . Molecular imaging of proliferation in malignant lymphoma. Cancer Res. 2006; 66(22):11055-61. DOI: 10.1158/0008-5472.CAN-06-1955. View

16.

Gowrishankar G, Hardy J, Wardak M, Namavari M, Reeves R, Neofytou E . Specific Imaging of Bacterial Infection Using 6″-F-Fluoromaltotriose: A Second-Generation PET Tracer Targeting the Maltodextrin Transporter in Bacteria. J Nucl Med. 2017; 58(10):1679-1684. PMC: 5632736. DOI: 10.2967/jnumed.117.191452. View

17.

Adhikari E, Liu Q, Burton C, Mockabee-Macias A, Lester D, Lau E . L-fucose, a sugary regulator of antitumor immunity and immunotherapies. Mol Carcinog. 2022; 61(5):439-453. PMC: 9097813. DOI: 10.1002/mc.23394. View

18.

Sun H, Sloan A, Mangner T, Vaishampayan U, Muzik O, Collins J . Imaging DNA synthesis with [18F]FMAU and positron emission tomography in patients with cancer. Eur J Nucl Med Mol Imaging. 2004; 32(1):15-22. DOI: 10.1007/s00259-004-1713-8. View

19.

Zhao C, Li P, Deng Z, Ou H, McGlinchey R, OHagan D . Insights into fluorometabolite biosynthesis in Streptomyces cattleya DSM46488 through genome sequence and knockout mutants. Bioorg Chem. 2012; 44:1-7. DOI: 10.1016/j.bioorg.2012.06.002. View

20.

Phelps M . Emission computed tomography. Semin Nucl Med. 1977; 7(4):337-65. DOI: 10.1016/s0001-2998(77)80042-1. View